Just weeks after joining the Chemring (CHG) board, non-executive director Andy Hamment has splashed out £150,000 on a maiden stake in the defence company. Mr Hamment is another of chief executive Mark Papworth’s appointments designed to rebuild the business, which under the old leadership had issued a string of profit warnings and convinced potential suitor Carlyle to walk away. Having worked in the industry most of his life and been part of the management buyout team that created Ultra Electronics, he will no doubt offer wise counsel.
And Mr Papworth will need it. Lower volumes, production delays and a shrinking order book smashed underlying earnings in the first half and sales slumped at both the countermeasures and pyrotechnics and munitions divisions. Troop withdrawal from Afghanistan, estimated at 15 per cent of group orders, will not help, either. If that business cannot be replaced, more cost savings will be needed to underpin the two-year recovery strategy.
Clearly, we’re concerned about the short-term outlook and threat of more aggressive cost reductions in the US. Many of Chemring’s businesses are short-cycle in nature and visibility is poor. Clearly, Mr Hamment is more bullish. Others are, too, and the share price has broken above 300p for the first time in six months. Yes, that’s encouraging, but it does not yet confirm an upward trend, and we would rather wait until the fundamentals improve. Hold
Lee Wild
Britvic’s finance director offloads on a high
Britvic’s (BVIC) share price has risen 79 per cent in the past year to 540p, despite falling sales and profits, with a recent improvement driven by strong pricing and cost control, rather than volume growth. But, with the share price at a five-year high, it’s perhaps no wonder that Britvic’s finance director, John Gibney, offloaded 35 per cent of his stake in the beverages company. On 26 July he sold 130,000 shares, priced at 519p each, giving him a windfall of £674,700. That leaves him with 243,813 shares. The news came as we changed our view on Britvic, and tipped the stock as a sell on 25 July. Our reasoning was that volumes are falling, trading is tough in core markets and debt is high. We believe a potential merger with peer AG Barr, now scrapped, would have been good for Britvic as it would have created cost savings and made commercial and strategic sense. Management claims Britvic’s performance has improved significantly since it first started courting the idea of a merger with AG Barr, but, as we spelled out in our sell tip, we can’t see that it has. Planned cost savings and restructuring is certainly good news, but this is major change that will be challenging to implement against weak consumer spending and a fiercely competitive market. However, Britvic is doing well in the US, where it is rolling out Fruit Shoot, and increased investment in international expansion should also help. That said, the fast-growing international division represents a tiny portion of overall revenue.
We continue to rate the shares as a sell.
Julia Bradshaw
Buys
Company | Director | Date | No. of shares | Price (p) | Value (£) | Total shares held | Value (%) |
---|---|---|---|---|---|---|---|
Beazley | Angela Crawford-Ingle | 24 Jul 13 | 13,500 | 220.7 | 29,795 | 13,500 | 0.002 |
Chemring | Andrew Hamment | 24 Jul 13 | 50,000 | 301 | 150,500 | 50,000 | 0.026 |
Croda | Martin Flower | 24 Jul 13 | 2,000 | 2424.9924 | 48,500 | 27,925 | - |
Europa Oil & Gas | Hugh Mackay (ceo) | 25 Jul 13 | 73,960 | 9.4 | 6,952 | 860,823 | 0.62 |
Greenko | Keith Henry (ch) | 25 Jul 13 | 20,000 | 119 | 23,800 | 40,000 | 0.03 |
Maven Income & Growth VCT 5 | Charles Young | 26 Jul 13 | 20,000 | 24.75 | 4,950 | 35,643 | 0.059 |
Maven Income & Growth VCT 5 | Gordon Humphries | 26 Jul 13 | 20,000 | 25.5 | 5,100 | 31,602 | 0.052 |
Monks Investment Trust | Karl Sternberg | 30 Jul 13 | 2,000 | 363.48 | 7,270 | 3,983 | 0.0017 |
SABMiller | GC Bible | 26 Jul 13 | 1,150 | 3129.18 | 35,986 | - | - |
Synectics | John Shepherd (ceo) | 26 Jul 13 | 7,300 | 410 | 29,930 | 468,739 | 2.6 |
Trap Oil | Scott Richardson Brown (fd) | 26 Jul 13 | 180,000 | 11 | 19,800 | 730,000 | 0.321 |
Verona Pharma | Claire Poll | 24 Jul 13 | 1,000,000 | 1.7 | 17,000 | 4,750,000 | 1.41 |
Vp | Alison Bainbridge | 24 Jul 13 | 5,500 | 408 | 22,440 | 21,500 | 0.05 |
Vp | Neil Stothard | 24 Jul 13 | 8,500 | 407 | 34,595 | 681,576 | 1.7 |
Wincanton | David Radcliffe | 29 Jul 13 | 25,000 | 74.125 | 18,531 | 25,000 | - |
Wolseley | Pilar López | 25 Jul 13 | 1,000 | 3168 | 31,680 | 1,000 | 0.0004 |
Wolseley | Gareth Davis | 29 Jul 13 | 3,250 | 3150 | 102,375 | 15,721 | 0.0057 |
Sells
Company | Director | Date | No. of shares | Price (p) | Value (£) | Total shares held | Value (%) |
---|---|---|---|---|---|---|---|
BlackRock Emerging Europe | Neil England | 26 Jul 13 | 37,867 | 283.32 | 107,285 | 124,133 | 0.34 |
Britvic | John Gibney | 26 Jul 13 | 130,000 | 519 | 674,700 | 243,813 | 0.1 |
Brunner | Sir Marcus Worsley (deceased) | 24 Jul 13 | 14,500 | 503.50 | 73,008 | 108,700 | 0.25 |
Central Asia Metals | Dr Michael Price | 24 Jul 13 | 10,000 | 115.77 | 11,577 | 196,000 | 0.229 |
Central Asia Metals | Dr Michael Price | 25 Jul 13 | 190,000 | 114.92 | 218,348 | 6,000 | 0.007 |
Charles Stanley | Sir David Howard | 26 Jul 13 | 19,367 | 423 | 81,922 | 300,000 | 0.66 |
DCC | Tommy Breen | 24 Jul 13 | 45,000 | 2,708.5 | 1,218,825 | - | - |
Domino's Pizza | Lee Ginsberg (cfo) | 30 Jul 13 | 70,000 | 578.00 | 404,600 | 49,800 | 0.07 |
IG Group | Tim Hawkins | 24 Jul 13 | 100,000 | 566 | 566,000 | 1,621,183 | - |
Mobile Streams | Simon Buckingham (ceo) | 25 Jul 13 | 245,000 | 72.66 | 178,017 | 17,125,010 | 46.44 |
Morgan Advanced Materials | Paul Boulton | 25 Jul 13 | 3,000 | 305.8039 | 9,174 | 8,699 | 0.0031 |
Sainsbury, J | Tim Fallowfield | 25 Jul 13 | 4,000 | 395 | 15,783 | 401,329 | - |
Table compiled by Robert Ansted
Key to abbreviations: ch = chairman; ce = chief executive; cfo = chief financial officer; fd = finance director; coo = chief operating officer; cs =company secretary; md = managing director